Certain dosage strengths of Zepbound ™ (tirzepatide) will be in limited supply at least through the end of April 2024, according to the Food and Drug Administration (FDA)’s Drug Shortages ...

The company is now offering 7.5 mg and 10 mg vials, higher doses than it's offered since launching Zepbound vials in August. It’s also slashing the cost of 2 mg and 5 mg vials by $50 a month.

A four-week supply of the 7.5-milligram and 10-milligram single-dose vials are $499 at first fill and refills within 45 days, and then $599 and $699, respectively.

The price for Zepbound, the popular weight-loss drug sold by Eli Lilly, is getting reduced. A four-week supply of the 2.5 mg dose will cost $399; the 5 mg dose will cost $549.

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

Launching the Zepbound Self Pay Journey Program, which reduces the price of the 7.5 mg ($599) and 10 mg ($699) doses to $499 per month at first fill and refills that happened within 45 days of ...

The remaining four doses—2.5 mg, 7.5 mg, 10 mg, and 15 mg—are currently unaffected by availability issues, ensuring continued access for consumers seeking the medication.

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with competitor Eli Lilly’s Zepbound. In a ...

A four-week supply of the 7.5-milligram and 10-milligram single-dose vials are $499 at first fill and refills within 45 days, and then $599 and $699, respectively.